Trytosaveabit OP amiable Llama_6295 : Yes it is! I sold for like 17% green! And haven’t got back in yet! It’s on my “ update look at your notes “ list! That I was supposed to look at this past weekend! Hehehe. But got busy doing stuff around the house! Hehehe. GL

Arrayfunction : Interesting this news caused so much of a kerfuffle. Getting the participants and starting phase II means they still haven't proved it actually works yet

Trytosaveabit OP Arrayfunction : The early data suggests, so far anyway, that it could end up being the standard for care? But yes if. And it a long way from that. But this is how it moves forward

Arrayfunction Trytosaveabit OP : You are definitely correct there! It's crazy how much of bio-tech is effectively just setting money on fire and hoping for the best!
My thoughts were more around the high risk approach they are taking running phase II/III at the same time. That signals to me either they are extremely confident about the drug based on unreleased efficacy data and want to double-time on getting it to market or the company has decided it is closing its doors regardless of the outcome (so either getting a patent to sell or going bankrupt)
The 2nd one is a lot more likely given the mountain of extra red tape running simultaneously adds - so not going near it as a long investor. But I hope your king of swing style can get some good returns on it!